Sponsor
Biocon Biologics UK Limited
16 Great Queen Street, WC2B 5AH, United Kingdom
About the sponsor
Research activity is centred on breast cancer, with a specific focus on hormone receptor negative and HER2-positive disease in early stage and locally advanced settings.
- HER2-positive breast cancer
- Hormone receptor negative disease
- Early stage breast cancer
- Locally advanced breast cancer
The clinical interest in this area aligns with treatment strategies used in neoadjuvant therapy for patients who have not previously received chemotherapy.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.